What is the current Somalogic market capitalization?
The current market capitalization of Somalogic is 386.38 M USD.
Somalogic Market capitalization 2024
Somalogic Market capitalization
386.38 M USD
Ticker
SLGC
ISIN
US83444K1051
WKN
A3C14K
In 2024, Somalogic's market cap stood at 386.38 M USD, a -38.01% increase from the 623.27 M USD market cap in the previous year.
The Somalogic Market capitalization history
| YEAR | Market Capitalization (undefined USD) |
|---|---|
| 2022 | 1 |
| 2021 | 2.14 |
| 2020 | - |
| 2019 | - |
Somalogic Aktienanalyse
What does Somalogic do?
SomaLogic Inc is a diagnostic biotech company specializing in a new way of clinically diagnosing diseases. It was founded in 2000 by Larry Gold, a renowned researcher and pioneer in the field of molecular diagnostics. The idea behind Somalogic arose from the need to bridge the gap between clinical needs and conventional diagnostic methods. SomaLogic's business model can be described as a service provider and licensee. The company offers its customers a wide range of products and services, from technology development to clinical disease diagnosis. The model is based on Somalogic's unique ability to measure a large number of proteins simultaneously, thus creating a comprehensive picture of their biological activity. The spheres of Somalogic encompass three main areas: proteins, data, and biomedicine. The protein sphere refers to Somalogic's core competence in the field of proteomics. The company has developed a proprietary technology that allows for the measurement of up to 5000 proteins in a single sample. Somalogic's technology is based on a special sample format called "SOMAScan," which utilizes proprietary aptamer technology to achieve ultra-high protein molecular signature accuracy. Somalogic's data sphere is deeply rooted in both the protein sphere and the biomedicine sphere. The company has a proprietary database that encompasses thousands of proteins. This database is continuously updated and expanded to provide increasingly robust quantitative protein data. The database enables Somalogic to identify and validate specific protein signatures associated with diseases. Somalogic also utilizes machine learning and artificial intelligence tools to take the interpretation of this data to the next level. The biomedicine sphere of Somalogic is the area where the company brings its diagnostic and therapeutic developments to the market. Somalogic works closely with pharmaceutical companies and clinical laboratories to develop clinical diagnostic tests based on its proprietary technology. The company has generated valid clinical data on a range of diseases and demonstrated the ability to identify biomarkers specifically associated with certain diseases. In its business development, Somalogic has created and licensed a wide range of products. The company has successfully formed partnerships with a number of companies and institutions to provide both proteomics tools and services. Some notable examples include partnerships such as collaboration with Biogen in the development of diagnostic tools for multiple sclerosis and other neurological disorders. Another example of Somalogic's product range is the successful collaboration with the New York State Health Department, where the company used its technology to investigate the SARS-CoV-2 virus. In this context, Somalogic generated information about specific biomarkers for COVID-19 and other masked and bound viral diseases. SomaLogic has the potential to change the way diseases are diagnosed and therapeutically treated. The company is on a path to revolutionize the diagnostic capabilities of the healthcare system and leave its mark on the healthcare market. Somalogic ist eines der beliebtesten Unternehmen auf Eulerpool.com.Market capitalization Details
Exploring Somalogic's Market Capitalization
Somalogic's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.
Year-to-Year Comparison
A yearly comparison of Somalogic's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.
Impact on Investments
Somalogic's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.
Interpreting Market Capitalization Fluctuations
Variations in Somalogic’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.
Frequently Asked Questions about Somalogic stock
What is market capitalization?
The market capitalization (German: Marktkapitalisierung, English: market capitalization, abbreviated as market cap, also known as stock exchange capitalization or market value) is the calculated total value of all shares of a publicly traded company like Somalogic.
How has the market capitalization of Somalogic developed in recent years?
The market capitalization of Somalogic has increased/decreased by -38.01% compared to the previous year.
What does market capitalization mean for investors?
The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company.
Why is market capitalization an important indicator for investors?
The market capitalization of a company reflects the current market consensus on the value of a publicly traded company's equity. It is determined by the supply and demand for the company's shares. Market capitalization is thus significantly influenced by expectations in the stock market regarding the future earnings power of the company, and as such, it can undergo significant fluctuations.
Why does the market capitalization fluctuate?
The market capitalization fluctuates along with the stock price, as the market capitalization is calculated based on the current price and the number of outstanding shares.
What role does market capitalization play in the valuation of Somalogic?
In order to compare the value of companies, it is helpful to consider not only the market capitalization but also the net debt of a company. A potential buyer of the entire company would also acquire the debts of the company. The enterprise value is the total value of a company or a stock corporation. The net financial indebtedness of the company is added to the market capitalization.
Does the market capitalization influence the performance of Somalogic?
There is no verifiable long-term evidence or study that stocks with a specific market capitalization (whether Mega/Large/Mid/Small Cap) would consistently yield significantly higher returns than others. There are occasional small studies (few stocks, short investment period) suggesting that certain classes may perform better or have higher risk, but none of them are 1. conclusive (cause-effect relationship is unclear, experiment is not repeatable) or 2. generalizable (generalization is not possible due to small sample size and time period).
Does the market capitalization of Somalogic have an influence on indices?
Some stock indices use market capitalization as index weighting. Stocks with a higher market capitalization are also weighted higher in the index. This is in contrast to equally weighted indices (all stocks have the same weighting) and free float weighted indices (market capitalization weighting, but only with the number of shares in free float).
How much dividend does Somalogic pay?
Over the past 12 months, Somalogic paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Somalogic is expected to pay a dividend of 0 USD.
What is the dividend yield of Somalogic?
The current dividend yield of Somalogic is .
When does Somalogic pay dividends?
Somalogic pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Somalogic?
Somalogic paid dividends every year for the past 0 years.
What is the dividend of Somalogic?
For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.
In which sector is Somalogic located?
Somalogic is assigned to the 'Health' sector.
Wann musste ich die Aktien von Somalogic kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Somalogic from 9/17/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 9/17/2024.
When did Somalogic pay the last dividend?
The last dividend was paid out on 9/17/2024.
What was the dividend of Somalogic in the year 2023?
In the year 2023, Somalogic distributed 0 USD as dividends.
In which currency does Somalogic pay out the dividend?
The dividends of Somalogic are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Somalogic
Our stock analysis for Somalogic Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Somalogic Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.